Your browser doesn't support javascript.
loading
Negative regulation of type I IFN signaling.
Arimoto, Kei-Ichiro; Miyauchi, Sayuri; Stoner, Samuel A; Fan, Jun-Bao; Zhang, Dong-Er.
Afiliação
  • Arimoto KI; Moores UCSD Cancer Center, University of California San Diego, La Jolla, California, USA.
  • Miyauchi S; Moores UCSD Cancer Center, University of California San Diego, La Jolla, California, USA.
  • Stoner SA; Moores UCSD Cancer Center, University of California San Diego, La Jolla, California, USA.
  • Fan JB; Moores UCSD Cancer Center, University of California San Diego, La Jolla, California, USA.
  • Zhang DE; Moores UCSD Cancer Center, University of California San Diego, La Jolla, California, USA.
J Leukoc Biol ; 2018 Jan 22.
Article em En | MEDLINE | ID: mdl-29357192
Type I IFNs (α, ß, and others) are a family of cytokines that are produced in physiological conditions as well as in response to the activation of pattern recognition receptors. They are critically important in controlling the host innate and adaptive immune response to viral and some bacterial infections, cancer, and other inflammatory stimuli. However, dysregulation of type I IFN production or response can contribute to immune pathologies termed "interferonopathies", pointing to the importance of balanced activating signals with tightly regulated mechanisms of tuning this signaling. Here, we summarize the recent advances of how type I IFN production and response are controlled at multiple levels of the type I IFN signaling cascade.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Leukoc Biol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Leukoc Biol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos